IL10 and neoplasm: In this study, vaccination with tumor antigen-loaded DCs plus lenalidomide led to the highest IFN-γ (Figure 3B) and lowest IL-10 (Figure 3C) production compared with the PBS control, tumor antigen-loaded-DCs or lenalidomide alone.